SuperCable vs. Conventional Steel Wire for Closure After a Median Sternotomy

NCT07251881 | Not Yet Recruiting FDA Device

• 2 other identifiers: 2025-D0040HumRes67145
• Study Type: interventional
• Target: 86
• Locations: 0 countries
• Sites: N/A

Brief Summary

During certain heart surgeries, the sternum is opened and must then be closed securely. The study compares two closure methods - steel wires and SuperCable - in terms of stability, healing, and patient satisfaction. This investigation aims to demonstrate that the iso-elastic properties of the SuperCable Sternal Closure System result in faster sternal bone healing, reduced postoperative pain, shorter hospital stay, and improved physical recovery compared to conventional steel wire sternal closure. Eighty-six patients are participating and are randomly assigned to one of the two groups. After the operation, pain, healing, and possible complications are checked. The patients are examined 3 and 6 months after the operation.

Conditions

Sternotomy

Outcome Measures

Primary Outcomes (1)

• Sternal bone healing

  Sternal bone healing, assessed via multiplanar CT-scans and a validated quantitative scoring algorithm (Stacy et al., 2014).

  day5, day90, day180 (might be waived depending on outcome on day90)

Secondary Outcomes (8)

• Length of Hospital Stay

  day90 (Visit 3)

• Postoperative pain assessed by using a 10-point visual analog scale (VAS)

  day1, day5, day90, day180

• Total use of opioid-like drugs

  day1, day5, day90, day180

• Upper Extremity Functional Index Score (UEFI)

  day90, day180

• Postoperative Quality of Recovery Scale (PostopQRS)

  day90, day180

Study Arms (2)

SuperCable®

EXPERIMENTAL

In the intervention group, sternal closure is performed using the SuperCable® Sternotomy Closure System.

Device: SuperCable®

Steel wires

ACTIVE COMPARATOR

In the control group, sternal closure is performed using conventional USP 7 (United States Pharmacopeia size-designation system) tool steel wires.

Device: Steel Wires

Interventions

SuperCable® DEVICE

Initially, CABG procedure is performed in standard fashion. In the intervention group, sternal closure is performed using the SuperCable® Sternotomy Closure System.

SuperCable®

Steel Wires DEVICE

Initially, CABG procedure is performed in standard fashion. In the control group, sternal closure is performed using conventional USP 7 (United States Pharmacopeia size-designation system) tool steel wires (Fumedica AG).

Steel wires

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Provision of Informed Consent: The subject must have signed and dated the informed consent form prior to any study-related procedures.
• Willingness and Ability to Comply: The subject must express a stated willingness to comply with all study procedures and be available for the duration of the study.
• Age and Sex:
• Age: The subject must be at least 18 years old.
• Sex: Both male and female subjects are eligible. In line with the "Sex and Gender in Research Involving Humans" recommendations, data will be stratified and analyzed by sex to identify any potential differences in outcomes.
• Language Competence: The subject must possess sufficient German language skills to accurately complete the postoperative survey
• Travel Capability: The subject must have the ability to travel for all planned study visits, including scheduled CT scans
• Surgical Procedure: The subject must be scheduled for elective coronary artery bypass graft (CABG) procedures, as this is the focus of the investigation
• Adherence to Visit Schedule: The subject must be willing to adhere to all scheduled visits and undergo CT scans as outlined in the study protocol

You may not qualify if:

• Pharmacological Restrictions: Current use of corticosteroids or any immunosuppressive medication
• Prior Treatments and Therapies: History of radiation therapy to the thorax
• Reproductive Considerations:
• Pregnancy, or the intent to become pregnant during the study period
• Lactation or current breastfeeding
• Allergic Reactions: Known allergic reactions to components of the conventional steel wire or SuperCable, specifically any known metal allergies (e.g., nickel or titanium).
• Example: Patients with a documented history of nickel allergy, including previous adverse reactions to products such as sternal cerclages, will be excluded
• Infectious or Febrile Conditions: Any febrile illness occurring immediately before the scheduled surgery
• Concurrent Investigational Treatments: Treatment with another investigational drug or medical device within two months preceding surgery, as well as during the current investigation
• Surgical History: Subjects who have undergone prior sternotomy and osteosynthesis (i.e., re-do patients) will be excluded
• Anatomical Considerations:
• Known sternal deformities that could compromise the outcome of the investigation
• Off-midline sternotomy approaches, as these do not align with the surgical technique under investigation
• Patient Residence and Follow-Up Feasibility: Subjects residing in remote regions, including those from interstate or overseas, where follow-up and adherence to the scheduled visits might be compromised

Sponsors & Collaborators

• University of Zurich: lead

Central Study Contacts

Hector Rodriguez, PD Dr. med.

CONTACT

+41432532687; hector.rodriguez@usz.ch

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 24, 2025
• First Posted: November 26, 2025
• Study Start: May 1, 2026
• Primary Completion (Estimated): July 1, 2027
• Study Completion (Estimated): July 1, 2027
• Last Updated: May 1, 2026

Record last verified: 2026-04